Entries of Reichle, A on the publication server
 | Up a level |
Number of items: 3.
Fiegl, M, Unterhalt, M, Kern, W, Braess, J, Spiekermann, K, Staib, P, Grüneisen, A, Wörmann, B, Schöndube, D, Serve, H 
, Reichle, A, Hentrich, M, Schiel, X, Sauerland, C, Heinecke, A, Rieger, C, Beelen, D, Berdel, W E, Büchner, T and Hiddemann, W
(2014)
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.
Leukemia 28 (5), pp. 1001-1007.
Fulltext not available.
, Reichle, A, Hentrich, M, Schiel, X, Sauerland, C, Heinecke, A, Rieger, C, Beelen, D, Berdel, W E, Büchner, T and Hiddemann, W
(2014)
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.
Leukemia 28 (5), pp. 1001-1007.
Fulltext not available.
Koenigsmann, M, Casper, J, Kahl, C, Basara, N, Sayer, H G, Behre, G, Theurich, S, Christopeit, M , Mohren, M, Reichle, A, Metzner, B, Ganser, A, Stadler, M, Uharek, L, Balleisen, L, Hinke, A, Hinke, R and Niederwieser, D
(2014)
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.
Bone Marrow Transplantation 49 (3), pp. 410-415.
Fulltext not available.
, Mohren, M, Reichle, A, Metzner, B, Ganser, A, Stadler, M, Uharek, L, Balleisen, L, Hinke, A, Hinke, R and Niederwieser, D
(2014)
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.
Bone Marrow Transplantation 49 (3), pp. 410-415.
Fulltext not available.
Plikat, K, Reichle, A, Elmlinger, M and Schölmerich, J
(2003)
Hypoglykämien bei malignem Hämangioperizytom der Leber.
DMW - Deutsche Medizinische Wochenschrift 128 (06), pp. 257-260.
Fulltext not available.